Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The impact of cytotoxic therapy on the risk of progression and death in clonal cytopenia(s) of undetermined significance.
Li MM, Baranwal A, Gurney M, Shah SN, Al-Kali A, Alkhateeb HB, Foran JM, Arana-Yi C, Ongie L, Chen D, Mangaonkar AA, McCullough K, Tefferi A, Lasho TL, Finke CM, Patnaik MM, Shah MV. Li MM, et al. Among authors: shah mv. Blood Adv. 2024 Apr 2:bloodadvances.2023012357. doi: 10.1182/bloodadvances.2023012357. Online ahead of print. Blood Adv. 2024. PMID: 38564774
Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms.
Alkhateeb HB, Nanaa A, Viswanatha D, Foran JM, Badar T, Sproat L, He R, Nguyen P, Jevremovic D, Salama ME, Greipp P, Gangat N, Tefferi A, Litzow MR, Mangaonkar AA, Shah MV, Patnaik M, Al-Kali A. Alkhateeb HB, et al. Among authors: shah mv. Blood Adv. 2022 Jan 25;6(2):528-532. doi: 10.1182/bloodadvances.2021005738. Blood Adv. 2022. PMID: 34644397 Free PMC article.
Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasms.
Shah MV, Mangaonkar AA, Begna KH, Alkhateeb HB, Greipp P, Nanaa A, Elliott MA, Hogan WJ, Litzow MR, McCullough K, Tefferi A, Gangat N, Patnaik MM, Al-Kali A, He R, Chen D. Shah MV, et al. Blood Cancer J. 2022 Jul 8;12(7):106. doi: 10.1038/s41408-022-00703-8. Blood Cancer J. 2022. PMID: 35803921 Free PMC article.
Bone marrow dendritic cell aggregates associate with systemic immune dysregulation in chronic myelomonocytic leukemia.
Mangaonkar AA, Reichard KK, Binder M, Coltro G, Lasho TL, Carr RM, Chiu A, Negron V, Hefazi M, Anagnostou T, Timm MM, Hiebert JW, Villasboas JC, Gonsalves WI, Gangat N, Shah M, Alkhateeb HB, Al-Kali A, Elliott MA, Begna KH, Wolanskyj-Spinner AP, Litzow MR, Hogan WJ, Ansell SM, Pardanani A, Tefferi A, Patnaik MM. Mangaonkar AA, et al. Blood Adv. 2020 Nov 10;4(21):5425-5430. doi: 10.1182/bloodadvances.2020002415. Blood Adv. 2020. PMID: 33152058 Free PMC article.
Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia.
Pophali P, Matin A, Mangaonkar AA, Carr R, Binder M, Al-Kali A, Begna KH, Reichard KK, Alkhateeb H, Shah MV, Tefferi A, Hogan WJ, Litzow MR, Patnaik MM. Pophali P, et al. Among authors: shah mv. Blood Cancer J. 2020 Nov 20;10(11):121. doi: 10.1038/s41408-020-00387-y. Blood Cancer J. 2020. PMID: 33219206 Free PMC article. Clinical Trial. No abstract available.
Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation.
Joshi M, Cook J, McCullough K, Nanaa A, Gangat N, Foran JM, Murthy HS, Kharfan-Dabaja MA, Sproat L, Palmer J, Pardanani A, Tefferi A, Begna K, Elliot M, Al-Kali A, Patnaik M, Shah MV, Hogan WJ, Litzow MR, Alkhateeb HB. Joshi M, et al. Among authors: shah mv. Blood Cancer J. 2021 Mar 4;11(3):49. doi: 10.1038/s41408-021-00437-z. Blood Cancer J. 2021. PMID: 33664234 Free PMC article. No abstract available.
Clinical, molecular, and prognostic comparisons between CCUS and lower-risk MDS: a study of 187 molecularly annotated patients.
Li M, Binder M, Lasho T, Ferrer A, Gangat N, Al-Kali A, Mangaonkar A, Elliott M, Litzow M, Hogan W, Pardanani A, Wolanskyj-Spinner A, Howard M, King RL, Shah M, Alkhateeb H, Begna K, Tefferi A, Finke C, Oliveira J, Ketterling R, Olteanu H, Patnaik MM. Li M, et al. Blood Adv. 2021 Apr 27;5(8):2272-2278. doi: 10.1182/bloodadvances.2020003976. Blood Adv. 2021. PMID: 33904893 Free PMC article. No abstract available.
Cardiac events in patients with acute myeloid leukemia treated with venetoclax combined with hypomethylating agents.
Johnson IM, Bezerra ED, Farrukh F, McCullough K, Al-Kali A, Alkhateeb HB, Begna K, Litzow MR, Hogan WJ, Shah MV, Patnaik MM, Tefferi A, Gangat N. Johnson IM, et al. Among authors: shah mv. Blood Adv. 2022 Sep 13;6(17):5227-5231. doi: 10.1182/bloodadvances.2022007333. Blood Adv. 2022. PMID: 35358999 Free PMC article. No abstract available.
234 results